Core Viewpoint - The State Council's Tariff Policy Committee has announced the "2026 Tariff Adjustment Plan," effective from January 1, 2026, aimed at optimizing import tariffs to promote high-quality development and meet the growing needs of the population [1][2]. Group 1: High-end Manufacturing and Technology Industry - The industry will benefit directly from reduced import tariffs on key components and advanced materials, such as hydraulic cushions and composite connectors, which will lower import costs and enhance supply stability [4]. - The tariff reduction is expected to alleviate financial pressure on companies importing critical semiconductor equipment, thereby accelerating domestic substitution processes and fostering a favorable development environment [4]. Group 2: Healthcare Sector - The tariff adjustments will lower import tariffs on medical products like artificial blood vessels and diagnostic kits, reducing procurement costs for domestic healthcare institutions and improving access to quality medical resources [4]. - The ongoing optimization of tariff policies will further decrease operational costs for healthcare companies, enhancing their market competitiveness [4]. Group 3: Foreign Trade and Retail - Foreign trade enterprises, particularly those engaged in cross-border operations, will benefit from tariff reductions, with products like coffee beans and automotive engines included in the "zero tariff" list [5]. - The rising demand in the duty-free shopping market, exemplified by a 54.9% year-on-year increase in Hainan's duty-free shopping amount, will drive growth in related industries such as shipping and logistics [5]. Group 4: Green Energy - The green energy sector will see advantages from reduced import tariffs on resource products, such as recycled black powder for lithium-ion batteries, lowering production costs for new energy battery manufacturers [5]. - The easing of tariffs is expected to provide more certainty for global investments in the new energy sector, further reducing export costs for China's photovoltaic and new energy vehicle industries [5].

来源：央视新闻客户端 三是加大保障和改善民生力度，助力加快建设健康中国，降低人造血管、部分传染病的 诊断试剂盒等医疗产品的进口关税。 此外，为增强国内大循环内生动力，根据国内产业发展和供需情况变化，在我国加入世 界贸易组织承诺范围内，取消微型电机、印花机、硫酸等商品的进口暂定税率，恢复实 施最惠国税率。 为服务科技发展和技术进步，支持循环经济和林下经济发展，2026年增列智能仿生机器人、生 物航空煤油、林下山参等本国子目。调整后，税则税目总数为8972个。 为持续深化经贸合作，促进区域融合发展，2026年根据我与34个贸易伙伴签署的24项自由贸易 协定和优惠贸易安排，继续对原产于上述贸易伙伴的部分进口货物实施协定税率。 为促进与最不发达国家的经贸合作，帮助最不发达国家发展，2026年继续给予43个与我建交的 最不发达国家100%税目产品零关税待遇；根据亚太贸易协定以及我与有关东盟成员国政府间换 文协议，继续对原产于孟加拉国、老挝、柬埔寨、缅甸的部分进口货物实施特惠税率。 les & FR 点击下载中国基金报客户端 国务院关税税则委员会：明年起对部分商品进口关税税率和税目进行调整 国务院关税税则委员会发布《20 ...

Group 1 - The resurgence of COVID-19 in Asia has led to increased expectations for demand in testing and vaccine production, resulting in a collective surge in stock prices of related companies [1][3] - South Korean diagnostic kit manufacturer Sugentech saw its stock price rise by as much as 29%, while Japanese vaccine manufacturer Daiichi Sankyo's stock increased by 7.4% due to an upgraded target price from UBS [1] - Other companies, such as Shanghai Junshi Bioscience in Hong Kong, also experienced stock price increases, with a rise of 4.3% [1] Group 2 - The new wave of COVID-19 is spreading rapidly in Asia, with predictions that it may reach levels seen during last summer's peak, according to the Chinese Center for Disease Control and Prevention [3] - The Korea Disease Control and Prevention Agency (KDCA) has extended the seasonal COVID-19 vaccination period by two months until the end of June, particularly recommending early vaccination for vulnerable groups [3] - The stock prices of various South Korean COVID-19 testing and vaccine companies, including Humasis, LabGenomics, Seegene, and SD Biosensor, have generally increased, with SK Bioscience's stock rising by 7.2% [3]